Showing results (671-680 of 995) with videos related to
Sort By:
Pageof 100
European Journal of Haematology|September 30, 1998
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual diseaseM Clavio, M Miglino, M Spriano, et al.British Journal of Cancer|September 8, 2012
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancerE Rossi, M Fassan, M Aieta, et al.Journal of Endocrinological Investigation|March 2, 2021
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategyR E Rossi, A C Milanetto, V Andreasi, et al.The American Journal of Medicine|May 1, 1996
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian RegistryG Finazzi, V Brancaccio, M Moia, et al.British Journal of Cancer|June 26, 2008
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsF Cappuzzo, M Varella-Garcia, G Finocchiaro, et al.European Review for Medical and Pharmacological Sciences|June 8, 2019
A novel biomarker score for the screening and management of patients with plasma cell proliferative disordersU Basile, F Gulli, M A Isgrò, et al.Leukemia & Lymphoma|May 7, 1998
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.Leukemia|June 1, 1996
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.British Journal of Cancer|October 29, 2014
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patientsA D'Incecco, M Andreozzi, V Ludovini, et al.British Journal of Cancer|August 2, 2012
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancerG Minuti, F Cappuzzo, R Duchnowska, et al.Pageof 100